Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $29.4 million.

  • Inspire Medical Systems' Shares Outstanding (Weighted Average) fell 132.55% to $29.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $29.4 million, marking a year-over-year decrease of 132.55%. This contributed to the annual value of $29.4 million for FY2025, which is 132.55% down from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Shares Outstanding (Weighted Average) is $29.4 million, which was down 132.55% from $29.5 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Shares Outstanding (Weighted Average) ranged from a high of $29.9 million in Q3 2024 and a low of $27.1 million during Q1 2021
  • For the 5-year period, Inspire Medical Systems' Shares Outstanding (Weighted Average) averaged around $28.7 million, with its median value being $29.3 million (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 1232.52% in 2021, then plummeted by 132.55% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Shares Outstanding (Weighted Average) stood at $27.3 million in 2021, then rose by 2.97% to $28.1 million in 2022, then rose by 4.38% to $29.3 million in 2023, then grew by 1.57% to $29.8 million in 2024, then dropped by 1.33% to $29.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $29.4 million in Q4 2025, compared to $29.5 million in Q3 2025 and $29.6 million in Q2 2025.